| http://www.w3.org/ns/prov#value | - However, several events in recent years, including new clinical study results, ESA product label revisions, and coverage and reimbursement policy changes, have had an impact on ESA dosing patterns and consequently on hemoglobin (Hb) distribution ... 105 Oxidative DNA damage in chronic renal failure patients.
|
